Tamoxifen-resistant cells sensitive to oestradiol

Symptomatic presentation of cancer in patients diagnosed following emergency self-referral and prior general practice consultations.

Postgraduate medicine·2026

Missed opportunities for earlier cancer diagnosis within specific pathways to emergency presentation.

Future oncology (London, England)·2025

Patients' perceptions on reasons for self-referring to the emergency department shortly before a cancer diagnosis: a qualitative study.

The British journal of general practice : the journal of the Royal College of General Practitioners·2025

Acceptability and somatic mutations in cervicovaginal self-sampling for early endometrial cancer detection in women with Lynch syndrome.

International journal of cancer·2025

Clinical characterisation of patients diagnosed with cancer following emergency self-referral.

Cancer epidemiology·2024

Time to Diagnosis and Presenting Symptoms of Patients Diagnosed With Cancer Through Emergency and Nonemergency Routes: A Large Retrospective Study From a High-Volume Center.

JCO oncology practice·2024

Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial.

The Lancet. Oncology·2026

Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial.

The Lancet. Oncology·2026

Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial.

The Lancet. Oncology·2026

Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial.

The Lancet. Oncology·2026

Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial.

The Lancet. Oncology·2026

Erratum: Prevalence and management of testicular incidentaloma in men with male factor infertility: Experience of a high-volume tertiary center.

Urology annals·2026

[PRIMARY MALIGNANT LYMPHOMA OF THE RENAL PELVIS : A CASE REPORT].

Hinyokika kiyo. Acta urologica Japonica·2026

Two cases of pregnancy during the fourth year of 68 mg etonogestrel implant use.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026

46,X,+mar(Y) as a Rare Etiology of Non-obstructive Male Infertility.

Journal of human reproductive sciences·2026

Online Abortion Information for Unintended Pregnancy in Australia: An Evaluation.

The Australian & New Zealand journal of obstetrics & gynaecology·2026

FDG PET/CT in a Case of α-Fetoprotein-Producing Urothelial Carcinoma With Hepatoid Differentiation of the Renal Pelvis.

Clinical nuclear medicine·2026

Related Experiment Videos

Tamoxifen-resistant cells sensitive to oestradiol

Related Concept Videos

Symptomatic presentation of cancer in patients diagnosed following emergency self-referral and prior general practice consultations.

Missed opportunities for earlier cancer diagnosis within specific pathways to emergency presentation.

Patients' perceptions on reasons for self-referring to the emergency department shortly before a cancer diagnosis: a qualitative study.

Acceptability and somatic mutations in cervicovaginal self-sampling for early endometrial cancer detection in women with Lynch syndrome.

Clinical characterisation of patients diagnosed with cancer following emergency self-referral.

Time to Diagnosis and Presenting Symptoms of Patients Diagnosed With Cancer Through Emergency and Nonemergency Routes: A Large Retrospective Study From a High-Volume Center.

Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial.

Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial.

Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial.

Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial.

Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial.

Erratum: Prevalence and management of testicular incidentaloma in men with male factor infertility: Experience of a high-volume tertiary center.

[PRIMARY MALIGNANT LYMPHOMA OF THE RENAL PELVIS : A CASE REPORT].

Two cases of pregnancy during the fourth year of 68 mg etonogestrel implant use.

46,X,+mar(Y) as a Rare Etiology of Non-obstructive Male Infertility.

Online Abortion Information for Unintended Pregnancy in Australia: An Evaluation.

FDG PET/CT in a Case of α-Fetoprotein-Producing Urothelial Carcinoma With Hepatoid Differentiation of the Renal Pelvis.

Related Experiment Videos

Tamoxifen-resistant cells sensitive to oestradiol

Related Concept Videos

Related Articles